Patent · US Active

Pyrrolobenzodiazepine-anti-CD22 antibody conjugates

US10722594B2 · kind B2 · utility

1Cited by

78References

11Claims

0Family size

Assignees

ADC THERAPEUTICS SA · CH
MedImmune Limited · US

Inventors

Philip Wilson Howard · London, GB
Patricius Hendrikus Cornelis Van Berkel · Épalinges, CH

Key dates

Filing date	Jan 31, 2018
Grant date	Jul 28, 2020
Priority date	—
Expiry date	May 31, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Conjugates of an isolated humanized, anti-CD22 antibody with PBD dimers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.